Yuk–Kong Lau

494 citations
11 papers · 376 indexed · h-index 10
Topics
Antiplatelet Therapy and Cardiovascular Diseases (7 papers)Atrial Fibrillation Management and Outcomes (7 papers)Heparin-Induced Thrombocytopenia and Thrombosis (3 papers)
Partner nations
ChinaHong KongAustralia

In The Last Decade

Yuk–Kong Lau

11 papers receiving 363 citations

Peers

Yuk–Kong Lau
Comparison fields: 5 of 61
  • Cardiology and Cardiovascular Medicine 246
  • Surgery 133
  • Gastroenterology 105
  • Pharmacology 88
  • Pulmonary and Respiratory Medicine 46
Replace Claus Aalykke with:
Claus Aalykke Denmark
J Bonnet France
Juan Carlos Claro Chile
Kevin C. Kelly United States
Matej Samoš Slovakia
R. W. Galloway United Kingdom
G Tildesley United Kingdom
Tomáš Bolek Slovakia
Norman A. Christensen United States
G. Valerio Italy
Yuk–Kong Lau relative to Claus Aalykke Denmark Claus Aalykke's profile →
Citations per field
00.5×1.5×
Claus Aalykke · 1×
Citations per year

Countries citing papers authored by Yuk–Kong Lau

Since Specialization
Citations

This map shows the geographic impact of Yuk–Kong Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuk–Kong Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuk–Kong Lau more than expected).

Fields of papers citing papers by Yuk–Kong Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuk–Kong Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuk–Kong Lau. The network helps show where Yuk–Kong Lau may publish in the future.

Co-authorship network of co-authors of Yuk–Kong Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Yuk–Kong Lau. A scholar is included among the top collaborators of Yuk–Kong Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuk–Kong Lau. Yuk–Kong Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 19
2 14
3 46
4 15
5 25
6 87
7 80
8 56
9
A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
6
10 11
11
Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention.
17

About Yuk–Kong Lau

Yuk–Kong Lau is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Otorhinolaryngology, having authored 11 papers that have together received 376 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). The work is most often cited by research in Gastroenterology (105 citations), Cardiology and Cardiovascular Medicine (246 citations) and Internal Medicine (40 citations). Yuk–Kong Lau has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Kwok–Fai Lam, Fook–Hong Ng, Siu‐Yin Wong, Benjamin C.Y. Wong, Wai–Cheung Yuen, Carolyn Kng, Benjamin C.Y. Wong, Pierre Chan, Andrew Li and Francis K.L. Chan. Their work appears in journals such as Gastroenterology, The American Journal of Cardiology and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026